Detlev Boison
Overview
Explore the profile of Detlev Boison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
6046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campbell A, Lai T, Wahba A, Boison D, Gebril H
Exp Neurol
. 2024 Aug;
381:114930.
PMID: 39173898
Traumatic brain injury (TBI) presents a significant public health challenge, necessitating innovative interventions for effective treatment. Recent studies have challenged conventional perspectives on neurogenesis, unveiling endogenous repair mechanisms within the...
2.
Purnell B, Bhasin J, Rust B, George S, Bah K, Lu T, et al.
Epilepsia
. 2024 Jul;
65(9):2798-2811.
PMID: 39018000
Objective: Respiratory arrest plays an important role in sudden unexpected death in epilepsy (SUDEP). Adenosine is of interest in SUDEP pathophysiology due to its influence on seizures and breathing. The...
3.
Alexander S, Fabbro D, Kelly E, Mathie A, Peters J, Veale E, et al.
Br J Pharmacol
. 2023 Dec;
180 Suppl 2:S289-S373.
PMID: 38123154
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of...
4.
Tscherner A, McClatchie T, Kaboba G, Boison D, Baltz J
Cells
. 2023 Oct;
12(20).
PMID: 37887344
Early preimplantation mouse embryos are sensitive to increased osmolarity, which can block their development. To overcome this, they accumulate organic osmolytes to maintain cell volume. The main organic osmolyte used...
5.
Daniels S, Boison D
Neuropharmacology
. 2023 Oct;
241:109756.
PMID: 37820933
Decreased ATPergic signaling is an increasingly recognized pathophysiology in bipolar mania disease models. In parallel, adenosine deficit is increasingly recognized in epilepsy pathophysiology. Under-recognized ATP and/or adenosine-increasing mechanisms of several...
6.
Oliveros A, Poleschuk M, Cole P, Boison D, Jang M
Int Rev Neurobiol
. 2023 Sep;
170:267-305.
PMID: 37741694
Chemotherapy has a significant positive impact in cancer treatment outcomes, reducing recurrence and mortality. However, many cancer surviving children and adults suffer from aberrant chemotherapy neurotoxic effects on learning, memory,...
7.
Guo M, Wang J, Xiong Z, Wang X, Yang Y, Zhang Y, et al.
Neuropathol Appl Neurobiol
. 2023 Jul;
49(4):e12926.
PMID: 37483117
Aims: Mesial temporal lobe epilepsy without hippocampal sclerosis (no-HS MTLE) refers to those MTLE patients who have neither magnetic resonance imaging (MRI) lesions nor definite pathological evidence of hippocampal sclerosis....
8.
Guo M, Zhang J, Wang J, Wang X, Gao Q, Tang C, et al.
Mol Neurobiol
. 2023 Apr;
60(8):4396-4417.
PMID: 37103687
Focal cortical dysplasia (FCD), a common malformation of cortical development, is frequently associated with pharmacoresistant epilepsy in both children and adults. Adenosine is an inhibitory modulator of brain activity and...
9.
Purnell B, Alves M, Boison D
Neurobiol Dis
. 2023 Mar;
179:106058.
PMID: 36868484
The epilepsies are a diverse spectrum of disease states characterized by spontaneous seizures and associated comorbidities. Neuron-focused perspectives have yielded an array of widely used anti-seizure medications and are able...
10.
Singla A, Dadario N, Singla A, Greenberg P, Yan R, Nanda A, et al.
PLoS One
. 2023 Jan;
18(1):e0274243.
PMID: 36716303
Background: Coronavirus disease 2019 (COVID-19) is an immunoinflammatory and hypercoagulable state that contributes to respiratory distress, multi-organ dysfunction, and mortality. Dipyridamole, by increasing extracellular adenosine, has been postulated to be...